TrialInternational journal of clinical oncology2019

Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety.

Hiroaki Tanioka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.